本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Boundless Bio, Inc.

1.41
-0.1000-6.62%
成交量:26.64萬
成交額:37.84萬
市值:3,156.37萬
市盈率:-0.49
高:1.50
開:1.49
低:1.37
收:1.51
52周最高:3.75
52周最低:1.00
股本:2,238.56萬
流通股本:1,646.21萬
量比:1.10
換手率:1.62%
股息:- -
股息率:- -
每股收益(TTM):-2.8839
每股收益(LYR):-3.8485
淨資產收益率:-42.65%
總資產收益率:-24.27%
市淨率:0.26
市盈率(LYR):-0.37

資料載入中...

2024/04/12

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/04/12

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/04/09

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/04/02

重要事件披露

Form 8-K - Current report
2024/03/28

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/03/26

SEC問詢函

Form CORRESP - Correspondence
2024/03/26

SEC問詢函

Form CORRESP - Correspondence
2024/03/21

[修訂]招股説明書

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2024/03/15

SEC問詢函

Form CORRESP - Correspondence
2024/03/09

SEC問詢函

Form CORRESP - Correspondence
2024/03/07

SEC問詢函

Form CORRESP - Correspondence
2024/03/06

招股説明書

Form S-1 - General form for registration of securities under the Securities Act of 1933
2020/01/15

員工持股計劃

Securities to be offered to employees in employee benefit plans, post-effective amendments
2020/01/15

員工持股計劃

Securities to be offered to employees in employee benefit plans, post-effective amendments
2020/01/15

員工持股計劃

Securities to be offered to employees in employee benefit plans, post-effective amendments
2020/01/15

員工持股計劃

Securities to be offered to employees in employee benefit plans, post-effective amendments
2020/01/15

交易所摘牌聲明

Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities
2020/01/15

重要事件披露

Current report, items 1.02, 2.01, 3.01, 3.03, 5.01, 5.02, 5.03, 8.01, and 9.01
2020/01/07

超過5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2019/12/16

重要事件披露

Current report, items 5.02 and 9.01